Arm’s May 6 Earnings Could Unlock $250 as AI Workloads Accelerate

2 weeks ago 14

Vandita Jadeja

Thu, April 30, 2026 astatine 12:25 PM CDT 4 min read

Quick Read

Arm (ARM) reported Q3 FY26 gross of $1.24B, up 26.4% twelvemonth implicit year, with royalty gross rising 27% to $737M connected Armv9 adoption.
The banal has surged 84.51% twelvemonth to date, and 24/7 Wall St. sets a $227.57 terms people (12.83% upside) with a bargain standing and 90% assurance level.
Armv9 royalty leverage and AI-driven licensing adoption are accelerating faster than operating borderline compression, positioning Arm for sustained maturation done fiscal 2027 arsenic the pending DreamBig Semiconductor acquisition closes and customized compute subsystems scale.
The expert who called NVIDIA successful 2010 conscionable named his apical 10 stocks and Arm wasn't 1 of them. Get them present FREE.

I americium stepping into Arm Holdings (NASDAQ:ARM) astatine a infinitesimal erstwhile the banal has astir doubled twelvemonth to date, royalty rates are climbing connected Armv9 adoption, and a caller net study lands successful little than a week. The setup is rich, the valuation is rich, and the exemplary inactive finds country to run.

Our 24/7 Wall St. terms people for Arm is $227.57, implying 12.83% upside from the $201.69 adjacent connected April 29, 2026. We complaint Arm a buy, with a assurance level of 90%. That is simply a high-conviction telephone grounded successful guardant net power, assemblage momentum, and a 72% bullish expert skew.

The expert who called NVIDIA successful 2010 conscionable named his apical 10 stocks and Arm wasn't 1 of them. Get them present FREE.

An infographic titled 'ARM NASDAQ 12-MONTH PRICE PREDICTION'. The main conception shows 'CURRENT PRICE $201.69' starring to 'UPSIDE +12.83%' and 'TARGET PRICE $227.57', with a greenish 'BUY' fastener and 'Confidence Level: 90%'. The 'HOW WE GOT THERE' conception displays barroom charts for 'TRAILING P/E: $201.69', 'FORWARD P/E: $234.75', and 'ANALYST CONSENSUS: $169.59 (Weighted 30%)', totaling a 'WEIGHTED BASE PRICE: $208.59'. 'OUR ADJUSTMENTS' shows 'SECTOR MOMENTUM: +', 'ANALYST BULLISHNESS: +', 'EARNINGS PRESSURE (-12.3% YoY): -', and 'VOLATILITY (BETA 3.34): -', starring to a 'FINAL TARGET: $227.57'. A greenish 'BULL CASE' container lists 'What Could Go Right' (Armv9 royalty premix & AI workloads, Custom compute subsystems, DreamBig Semiconductor integration) with a 'TARGET: $251.89'. A reddish 'BEAR CASE' container lists 'What Could Go Wrong' (Qualcomm/Nuvia litigation (Q4 2026), U.S. export controls & tariffs, Arm China concentration) with a 'TARGET: $186.30'. The bottommost enactment reiterates '[ BUY ] -> $227.57 (+12.83%)'.

Metric

Value

Current Price	$201.69
24/7 Wall St. Price Target	$227.57
Upside	12.83%
Recommendation	BUY
Confidence Level	90%

A Vertical April Sets Up the May 6 Earnings Report

Arm has surged 47.26% implicit the past period and 84.51% twelvemonth to date, recovering from a January debased adjacent $105. Shares present beryllium 29% beneath the 52-week precocious of $237.68 and astir treble the $100.02 52-week low.

The Q3 FY26 study connected February 4, 2026 showed gross of $1.24B, up 26.4% twelvemonth implicit year, with royalty gross rising 27% to $737M connected Armv9 adoption. Diluted EPS of $0.21 missed the $0.41 statement arsenic R&D jumped 38%.

Q1 FY26 results onshore May 6, 2026, aft marketplace close, and humanities net reactions person been volatile, with a 11.56% one-day popular aft Q3 and an 11.34% one-week driblet aft Q2.

Sundry Photography / iStock Editorial via Getty Images

The Case for $250+

Bulls reason Armv9 royalty mix, customized compute subsystems, and AI workloads from borderline to information halfway tin propulsion results good supra consensus. Our bull lawsuit targets $251.89, a 24.89% full return, with a highest adjacent $251.23 by January 2027. The pending DreamBig Semiconductor acquisition closing successful fiscal Q1 2027 adds networking and chiplet exposure.

The Risks Worth Watching

Valuation is the evident vulnerability. ARM trades astatine a P/E of 270 and a guardant P/E of 97, leaving small borderline for execution slippage. Operating borderline compressed to 15% from 18% arsenic R&D scaled.

Read Entire Article